Skip to main content
. 2019 Sep 6;14(9):e0215791. doi: 10.1371/journal.pone.0215791

Table 1. Clinical characteristics of participants in the different GFR categories.

Normal G1 G2 G3 G4 G5 P value
N 47 20 26 19 11 9
age 30.8 ±10.5 40.6 ±11.2 56.7 ±12.5 61.8 ±14.9 66.0 ±13.3 66.9 ±13.6 < 0.01
male,n (%) 21 (44.7) 10 (50.0) 20 (76.9) 15 (78.9) 6 (54.5) 6 (66.6) 0.693
height (cm) 164.3 ±8.9 166.4 ±8.5 165.3 ±8.6 163.7 ±8.5 163.9 ±11.2 158.2 ±7.9 0.378
weight (kg) 58.7 ±11.6 69.3 ±15.6 61.9 ±11.7 67.6 ±14.9 62.7 ±13.9 55.8 ±9.5 0.032
Body surface area (m2) 1.634 ±0.19 1.767 ±0.21 1.501 ±0.54 1.594 ±0.50 1.677 ±0.23 1.556 ±0.14 0.217
AST (U/L) 18.0 ±6.2 23.2 ±12.7 22.9 ±8.6 24.2 ±8.0 19.1 ±6.0 21.4 ±7.6 0.420
ALT (U/L) 16.1 ±15.5 23.8 ±12.1 19.2 ±9.1 20.6 ±11.1 11.7 ±3.7 15.2 ±4.1 0.029
creatinine (mg/dL) 0.718 ±0.15 0.684 ±0.16 0.952 ±0.22 1.716 ±0.45 2.245 ±0.70 5.143 ±2.33 < 0.01
cystatine-C (mg/dL) no data 0.710 ±0.07 1.007 ±0.11 1.657 ±0.24 2.415 ±0.33 4.021 ±0.66 < 0.01
urea nitrogen (mg/dL) 13.2 ±3.2 12.4 ±3.1 15.2 ±4.1 26.4 ±6.9 36.8 ±8.0 56.7 ±20.0 < 0.01
eGFR creat (ml/min/1.73m2) 93.0 ±12.9 92.4 ±18.6 63.3 ±14.3 33.0 ±9.9 23.2 ±6.2 10.2 ±3.6 < 0.01
eGFR cys (ml/min/1.73m2) no data 114.2 ±14.8 73.7 ±7.2 40.1 ±7.4 23.9 ±3.7 11.3 ±3.3 < 0.01
white blood cell (*109/L) 5.5 ±1.2 6.4 ±2.3 6.1 ±1.6 5.5 ±1.4 5.8 ±1.8 6.5 ±2.1 0.123
hemoglobin (g/dL) 13.6 ±1.5 14.4 ±1.6 13.8 ±1.5 13.1 ±1.6 11.7 ±1.3 10.8 ±1.4 < 0.01
hematocrit (%) 41.0 ±4.0 42.6 ±4.1 40.7 ±4.0 38.4 ±4.6 35.6 ±3.5 33.1 ±3.4 < 0.01
platelets (*109/L) 247.1 ±49.4 242.1 ±64.6 245.4 ±52.1 215.3 ±43.7 353.6 ±463.9 188.2 ±43.5 0.473

Data are presented as the mean ± standard deviation, as number (%).

GFR categories: Categorized according to the KDIGO 2012 by eGFRcys.

G1: eGFRcys ≥90 mL/min/1.73 m2; G2: eGFRcys = 60–90 mL/min/1.73 m2; G3: eGFRcys = 30–60 mL/min/1.73 m2; G4: eGFRcys = 15–30 mL/min/1.73 m2; G5: eGFRcys ≤15 mL/min/1.73 m2.

P value was calculated by one-way analysis of variance.